Grant Stuart 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Aug 6, 2010
Insider Transaction Report
Form 4
Grant Stuart
SR VP & CFO
Transactions
- Exercise/Conversion
Emp. Stock Option (Right to Buy)
2010-08-04−2,500→ 103,751 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2010-08-04$1.20/sh+2,500$3,000→ 14,217 total - Sale
Common Stock
2010-08-04$6.20/sh−2,500$15,500→ 11,717 total
Footnotes (1)
- [F1]Transacted under a 10b5-1 plan that was adopted on 11/23/2009.